| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/03/2007 | US7199216 Two covalently bonded peptide components, one component being an antigen associated with autoimmune disease, asthma, allergy or transplantation rejection, and the second being a T cell binding ligand modified to inhibit or suppress the activation of the class of T cells to which it selectively binds |
| 04/03/2007 | US7199108 Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines |
| 04/03/2007 | US7199103 Synthetic compounds and compositions with enhanced cell binding |
| 04/03/2007 | US7199102 Orally administered peptides synergize statin activity |
| 04/03/2007 | US7199100 Oligopeptides; antitumor agents, antiinflammatory agents, antiischemic agents, vision defects |
| 04/03/2007 | US7199098 Copolymer-1 improvements in compositions of copolymers |
| 04/03/2007 | US7199097 Peptide fragments having cell death inhibitory activity |
| 04/03/2007 | US7198951 Viral expression vector for use as heterologous gene and/or therapeutic protein delivery tools; genetic vaccine |
| 04/03/2007 | US7198944 for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis |
| 04/03/2007 | US7198942 Acetylcholine receptor subunits |
| 04/03/2007 | US7198935 Infectious pestivirus pseudo-particles containing functional Erns, E1, E2 envelope proteins |
| 04/03/2007 | US7198934 Genetic engineering; gene insertion; culture product |
| 04/03/2007 | US7198926 Preparation of (E)- and (Z)-2-methyl-2-butenoic acids |
| 04/03/2007 | US7198923 Method for the preparation of purified HCV RNA by exosome separation |
| 04/03/2007 | US7198920 HER-2/neu fusion proteins |
| 04/03/2007 | US7198918 Recombinant DNA formed by ligating; gene expression; suppressing proliferation; medicine/drugs; host cell |
| 04/03/2007 | US7198917 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens |
| 04/03/2007 | US7198916 Nucleotide sequences coding mutated fluorescent protein for use as improved diagnostic indicator in genetic engineering |
| 04/03/2007 | US7198914 Comprises nucleotide sequences coding g protein coupled receptor for identifying modulator for treatment and prevention of cardiovascular, respiratory, muscle, liver, gastrointestinal, urogenital and blood disorders |
| 04/03/2007 | US7198913 Nucleotide sequences coding polypeptide for use in the treatment of apoptosis, inflammatory and autoimmune disorders |
| 04/03/2007 | US7198912 Polynucleotides encoding a human G-protein coupled receptor, HGPRBMY39 |
| 04/03/2007 | US7198911 Identification and cloning of a novel human gene, RET16, involved in the intracellular signaling cascade |
| 04/03/2007 | US7198910 Nucleic acid encoding melanin-concentrating hormone receptor |
| 04/03/2007 | US7198903 Binding domains between presenilins and their substrates as targets for drug screening |
| 04/03/2007 | US7198898 PHOX2B polymorphisms as Hirschsprung's disease diagnostic markers and methods based thereon |
| 04/03/2007 | US7198892 Hepatitis-C virus type 4, 5 and 6 |
| 04/03/2007 | US7198891 Hepatitis C virus peptides and uses thereof |
| 04/03/2007 | US7198798 Providing to one or more endothelial cells an amount of an osteoprotegerin sufficient to promote endothelial morphogenesis |
| 04/03/2007 | US7198792 Alphaviral vector system comprising papilloma viral orgin of replication and antitumor agent for prevention and treatment urogenital cancer; gene therapy |
| 04/03/2007 | US7198790 Growth differentiation factor-5 |
| 04/03/2007 | US7198789 Methods and compositions for modulating interleukin-21 receptor activity |
| 04/03/2007 | US7198781 Chimeric interleukin-6 soluble receptor/ligand proteins |
| 04/03/2007 | US7198774 Non-invasive localization of a light-emitting conjugate in a mammal |
| 04/03/2007 | CA2328447C Adeno-associated virus vectors and uses thereof |
| 04/03/2007 | CA2276459C Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 04/03/2007 | CA2259950C Radiometal-binding peptide analogues |
| 04/03/2007 | CA2238295C Complementary adenoviral vector systems and cell lines |
| 04/03/2007 | CA2236679C Differentiation-suppressive polypeptide |
| 04/03/2007 | CA2193365C Polynucleotide vaccine for papillomavirus |
| 04/03/2007 | CA2176943C Mutants of bone morphogenetic proteins |
| 04/03/2007 | CA2162397C Ligands for flt3 receptors |
| 04/03/2007 | CA2157530C Somatostatin analogs containing chelating groups and their radiolabeled compositions |
| 04/03/2007 | CA2121559C Immunogenic artificial polypeptide |
| 04/03/2007 | CA2108770C Bmp-9 compositions |
| 04/03/2007 | CA2089661C Transgenic non-human animals capable of producing heterologous antibodies |
| 03/30/2007 | CA2560161A1 Production of recombinant human collagen |
| 03/29/2007 | WO2007035922A2 Aptamers to the human il-12 cytokine family and their use as autoimmune disease therapeutics |
| 03/29/2007 | WO2007035782A2 Protein kinase c peptide modulators of angiogenesis |
| 03/29/2007 | WO2007035716A2 Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof |
| 03/29/2007 | WO2007035693A2 Isonitrile biosynthetic genes and uses thereof |
| 03/29/2007 | WO2007035650A2 Methods for genetic control of insect infestations in plants and compositions thereof |
| 03/29/2007 | WO2007035600A2 Natriuretic activities |
| 03/29/2007 | WO2007035553A2 Methods and compositions for detecting neoplastic cells |
| 03/29/2007 | WO2007035410A1 Protein a production and purification without using animal derived components |
| 03/29/2007 | WO2007035382A2 Acaricidal compositions and methods of use thereof |
| 03/29/2007 | WO2007035341A1 Protein a production and purification without using animal derived components |
| 03/29/2007 | WO2007034986A1 Gene encoding cell wall mannoprotein and use thereof |
| 03/29/2007 | WO2007034782A1 Recombinant vector capable of increasing secretion of koji mold protease |
| 03/29/2007 | WO2007034603A1 Marker gene for malignant brain tumor and use thereof |
| 03/29/2007 | WO2007034507A2 Tetravalent dengue specific domain iii based chimeric recombinant protein |
| 03/29/2007 | WO2007034498A1 Atrial natriuretic peptide (anp) splice variants and methods of using same |
| 03/29/2007 | WO2007034490A2 Diastereomeric peptides for modulating t cell immunity |
| 03/29/2007 | WO2007034266A1 Method for the production of biologically active rhngf |
| 03/29/2007 | WO2007034166A2 Adjuvanted vaccine |
| 03/29/2007 | WO2007033529A1 A gene encoding antibacterial protein of fenneropenaeus chinensis and its recombination expression method and uses |
| 03/29/2007 | WO2007033497A1 Library from toxin mutants, and methods of using same |
| 03/29/2007 | WO2007033424A1 Compositions and methods for transfecting cells |
| 03/29/2007 | WO2007013807A3 Targeting-enhanced activation of galectins |
| 03/29/2007 | WO2007009816A3 Plexin d1 as a target for tumor diagnosis and therapy |
| 03/29/2007 | WO2006138527A3 Genes of an otitis media isolate of nontypeable haemophilus influenzae |
| 03/29/2007 | WO2006128864A3 Mutant strains of lactic acid bacteria having a non-phosporylable lactose permease |
| 03/29/2007 | WO2006126030A3 Malaria vaccines |
| 03/29/2007 | WO2006116717A3 Autologous somatic cells from peripheral blood and uses thereof |
| 03/29/2007 | WO2006116185A3 Methods for the treatment of multiple myeloma |
| 03/29/2007 | WO2006111745A3 Composition and method for treating viral infection |
| 03/29/2007 | WO2006110881A3 Yersinia polypeptide vaccines, antibodies and immunomodulatory proteins |
| 03/29/2007 | WO2006105993A3 Method for shielding functional sites or epitopes on proteins |
| 03/29/2007 | WO2006086454A3 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 03/29/2007 | WO2006079076A3 Yersinia spp. polypeptides and methods of use |
| 03/29/2007 | WO2006074341A3 Novel use |
| 03/29/2007 | WO2006073771A3 Polyethylene glycol linked mc4r or mc3r agonist peptides |
| 03/29/2007 | WO2006072625A8 Anti-kir combination treatments and methods |
| 03/29/2007 | WO2006066224A3 Virulence targeted antibiotics |
| 03/29/2007 | WO2006013336A9 Hpv vaccine comprising peptides from host cell proteins |
| 03/29/2007 | WO2005074524A3 Modified human interferon polypeptides and their uses |
| 03/29/2007 | WO2005053811A3 Biomolecule partition motifs and uses thereof |
| 03/29/2007 | WO2005053505A8 Use of gene ncsag4 for the diagnosis and prevention of neosporosis and as a marker for analysis of the pathogenesis |
| 03/29/2007 | WO2005035730A3 Dna sequences of the botulinum neurotoxin complex of type a-hall (allergan) strain |
| 03/29/2007 | WO2004081197A3 Immune response associated proteins |
| 03/29/2007 | WO2004043399A3 Methods and compositions for inducing immune responses and protective immunity by priming with alphavirus replicon vaccines |
| 03/29/2007 | US20070074313 Native antibiotic resistance genes |
| 03/29/2007 | US20070074308 Useful in protecting plants from insect damage; also included are micro-organisms and plants transformed with DNA sequence encoding an insecticidal Cry1Bf protein to obtain a plant resistant to insects |
| 03/29/2007 | US20070074307 Citrus tristeza virus resistance genes and methods of use |
| 03/29/2007 | US20070074306 Plant transcriptional activator and uses thereof |
| 03/29/2007 | US20070074296 RTD receptor |
| 03/29/2007 | US20070074295 Schizophrenia related gene |
| 03/29/2007 | US20070073047 Genes overexpressed by ovarian cancer and their use in developing novel therapeutics |
| 03/29/2007 | US20070073044 Homogeneous preparations of il-28 and il-29 |
| 03/29/2007 | US20070073043 Process for producing humanized chimera antibody |
| 03/29/2007 | US20070073042 Novel MHC II associated peptides |